iCAD

iCAD is a medical technology company that provides advanced software solutions for imaging diagnostics and treatment planning in the fields of oncology, vascular diseases, and orthopedics. The company was founded in 1984 and is headquartered in Nashua, New Hampshire.

iCAD's flagship product is its digital mammography and CAD (Computer-Aided Detection) solution, which uses artificial intelligence to detect abnormalities in breast tissue. The system combines digital mammography with CAD software to help radiologists identify potential malignancies earlier and more accurately. This has been shown to lead to better patient outcomes and earlier treatment.

In addition to its mammography and CAD solutions, iCAD also offers a range of other products for cancer treatment planning, including solutions for stereotactic biopsy and radiation therapy planning. These solutions are designed to help healthcare providers optimize their treatment plans and improve patient outcomes.

iCAD has a strong presence in the global healthcare industry, with over 1,400 distributors and more than 200 diagnostic imaging and radiation therapy centers in the United States and abroad. The company has also established partnerships with leading medical device manufacturers and research institutions to further develop its products and solutions.

iCAD's products and solutions have been recognized with numerous industry awards, including Best of Radiology 2009 and 2010, and the American Telemedicine Association's Leadership in Telehealth award in 2011. European CE marking certifications for the company's products have also been obtained.

Throughout its history, iCAD has focused on developing innovative solutions that improve healthcare outcomes and enhance patient care. The company continues to develop new technologies and partnerships to support its mission.